Quantbot Technologies’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.4K	Buy	2,472 +2,326	+1,593%	+$63.4K	﹤0.01%	1353
2025 Q4	$3.96K	Sell	146 -2,296	-94%	-$60.5K	﹤0.01%	1627
2025 Q3	$63.2K	Buy	+2,442	New	+$56.6K	﹤0.01%	1495
2024 Q4	–	Sell	-95	Closed	-$3.23K	–	1525
2024 Q3	$3.23K	Buy	+95	New	+$3.62K	﹤0.01%	1375
2022 Q2	–	Sell	-400	Closed	-$13K	–	1744
2022 Q1	$13K	Sell	400 -600	-60%	-$19.2K	﹤0.01%	1428
2021 Q4	$38K	Buy	1,000 +800	+400%	+$34.9K	﹤0.01%	1098
2021 Q3	$10K	Sell	200 -600	-75%	-$28.2K	﹤0.01%	1351
2021 Q2	$26K	Buy	+800	New	+$22K	﹤0.01%	1185
2016 Q2	–	Sell	-441	Closed	-$25K	–	1093
2016 Q1	$25K	Buy	441 +288	+188%	+$32.4K	﹤0.01%	979
2015 Q4	$36K	Buy	153 +26	+20%	+$5.67K	0.01%	856
2015 Q3	$20K	Buy	+127	New	+$35.9K	﹤0.01%	1023
2015 Q1	–	Sell	-27	Closed	-$7K	–	1089
2014 Q4	$7K	Sell	27 -631	-96%	-$157K	﹤0.01%	1018
2014 Q3	$127K	Buy	+658	New	+$143K	0.02%	817